Artificial vascular trees, the growing of heart tissue, nerve regeneration: The World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) held in Vienna this October offered an impressive display of current developments in tissue reconstruction and regeneration, Michael Krassnitzer reports
EKF Diagnostics, a worldwide manufacturer of point-of-care (POC) in-vitro diagnostic devices, has announced the European launch of its Quo-Lab POC HbA1c analyser.
Improving access to care still is a key goal of the Chinese national government.
Medica Media has done a good job. For years, the section in the world’s largest international medical trade fair has provided a meeting place for representatives from medical care, research and manufacturing organisations.
Rarely have the topics at the EHFG been so relevant to the current international economic crisis – reason enough for EH correspondent Christian Pruszinsky to interview the Forum’s founder and outgoing President Professor Günther Leiner.
Demand for health services in China is on the surge, and democracy pre-empts an upward trajectory.
MIR is a subcommittee of the European Society of Radiology (ESR), focused on all aspects of management, which help to “Make Imaging Relevant” in today´s healthcare. Join our conference, which will take place in the exciting and busy city of Milan (Italy) and will last two full days from Thursday, October 11 to Friday, October 12.
4,500 scientists, transplant teams and related social groups from 94 countries gathered in Berlin for the International Congress of the Transplant Society.
The worldwide scarcity of organ donations inevitably draws attention to the so-called Spanish model.
Research in the field is booming thanks to newly arriving methods to identify gene sequences. Scientists are interested in a wide range of issues from disease-relevant variations of human genetic information to the detection of viral genetic material that supports therapies. Several highlights of current research were presented this spring at the 9th International Symposium on Molecular…
During the annual American Association of Clinical Chemists (AAMC) convention and meeting held in July, the giants in the field of medical chemistry, including Siemens, Roche, IL/Werfen, Beckman Coulter, and Abbott, had a huge presence at the trade show, which filled two halls and packed in a hefty crowd. Jacquie Michels reports from Los Angeles, California.
The European Association of Hospital Pharmacists (EAHP) announced that online registration for its annual congress to take place next year from 13-15 March 2013 in Palais des Congrès, Paris, France is open. This congress’ theme is “Improving patient outcomes – a shared responsibility”.
John Brosky reports on a ground-breaking trial and how CT-FFR may change the practice of invasive cardiology and cardiac surgery.
Scientists state concern for both human and environmental health from a very commonly used antibacterial/antifungal agent. Brenda Marsh reports
Cardiologists are increasingly concerned about patients with persistent hypertension demanding a new technique, in the absence of clinical proof of its long-term benefit. As more related devices are launched, John Brosky reports on the procedure, drawbacks, and a potential €2 billion market.
Over the last five years the tiniest particles have attracted large attention in relation to the diagnosis and treatment of cardiovascular disease. Indeed, as in other medical disciplines, nanotechnology is advancing in cardiology despite as yet insufficient research on the extent of its effect and double blind studies to confirm findings
Initially limited to the aortic valve, interventions are becoming routine for the mitral valve. Thus the only available product has enjoyed huge commercial success – until now. Report: Holger Zorn
More anatomy details, real-time visualisation of catheter movement, and reduced exposure – MRI has promising potential in rhythmology, explain Professor Matthias Gutberlet and PD Dr Christopher Piorkowski, at the Heart Centre, University Hospital Leipzig, Germany.
The case-based approach holds considerable promise for medical science. In a way, it’s a return to the roots, since this approach was common at the dawn of modern medicine. A case serves as a narrative that can be explored interactively in order to draw a conclusion, determine a course of action, or debate issues in a realistic context. Spanish cardiac imaging consultant Dr Rafael Vidal Perez,…
Cardiovascular diseases, the most common cause of death in the West, includes diseases for which early detection is an important objective in cardiac imaging – particularly for coronary artery stenosis. Diagnosis is often made in the cardiac catheter laboratory. Now, however, CT scanning advances provide a lower impact alternative to that invasive exam. PD Dr Thomas Schlosser, Consultant at the…
The biggest cause of death for most adult women in industrialised nations is coronary heart disease (CHD). Why the disease affects the genders differently is still not fully understood. European Hospital Editor Brigitte Dinkloh asked Professor Rafaelle Bugiardini MD FESC, from the Department of Internal Medicine Department, University of Bologna, whether he could explain the reasons and what…
One heart – One Team, the motto for this year’s German Society for Thoracic and Cardiovascular Surgery Congress emphasises that cardiac surgeons and cardiologists must now work more in tandem for their mutual patients. This is not just a short-lived three-day slogan, but a daily reality at the University Heart Centre Hamburg, as EH correspondent Holger Zorn reports
A new generation of cardiovascular implantable electronic devices (CIEDs) includes the Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronisation Therapy Defibrillator (CRT-Ds) and Cardiac Resynchronisation Therapy Pacemakers (CRT-Ps). Professor W R Bauer at University Hospital Würzburg has been significantly involved in their development, EH Editor Ralf Mateblowski to ask him about…
Could bone marrow cells prolong life? Recruitment of 3,000 patients will begin across the EU later this year for the BAMI (Bone Marrow Cells in Acute Myocardial Infarction) study, which will test whether stem cells taken from bone marrow and administered after a heart attack will prolong life. Mark Nicholls reports